Volume: 55 Issue: 3
Year: 2024, Page: 479-492, Doi: https://doi.org/10.51966/jvas.2024.55.3.479-492
Received: July 30, 2024 Accepted: Aug. 13, 2024 Published: Sept. 30, 2024
Animal models have been critical in understanding the pathogenesis, transmission, and therapeutic interventions for COVID-19, caused by SARS-CoV-2. The primary challenges include species-specific differences in viral receptor expression, particularly the ACE2 receptor, and immune system responses, which can affect how closely these models mimic human COVID-19 pathology. Additionally, ethical concerns around the use of animals, especially non-human primates, and logistical issues such as high costs, housing requirements, and limited availability of certain models, further complicate research efforts. Transgenic mice expressing human ACE2 (hACE2) are widely used because of their ease of handling and cost-effectiveness. Other animal models include non-human primates, hamsters, cats, and ferrets, which were used to study viral transmission and host-pathogen interactions. The rapid dynamics of the SARSCoV-2 evolution is one of the challenges and the complementary use of multiple models provides a more comprehensive understanding of the disease. Nonetheless, these models have been essential for rapid advancements in COVID19 vaccine and therapeutic development, offering insights that continue to guide public health strategies. The review discusses the various animal models used in SARS-CoV-2 research, the outcomes, and the challenges and questions to be addressed
Keywords: Animal models, SARS-CoV-2, COVID-19
Abdelnabi, R., Foo Caroline, S., Kaptein Suzanne, J.F., Boudewijns, R., Vangeel, L., De Jonghe, S., Jochmans, D., Weynand, B. and Neyts, J. 2022. A SCID Mouse Model To Evaluate the Efficacy of Antivirals against SARS-CoV-2 Infection. J. Virol. 96: e00758-00722.
Bao, L., Deng, W., Gao, H., Xiao, C., Liu, J., Xue, J., Lv, Q., Liu, J., Yu, P., Xu, Y., Qi, F., Qu, Y., Li, F., Xiang, Z., Yu, H., Gong, S., Liu, M., Wang, G., Wang, S., Song, Z., Zhao, W., Han, Y., Zhao, L., Liu, X., Wei, Q. and Qin, C. 2020a. Reinfection could not occur in SARS-CoV-2 infected rhesus macaques. bioRxiv, 2020.2003.2013.990226.
Bao, L., Deng, W., Huang, B., Gao, H., Ren, L., Wei, Q., Yu, P., Xu, Y., Liu, J., Qi, F., Qu, Y., Wang, W., Li, F., Lv, Q., Xue, J., Gong, S., Liu, M., Wang, G., Wang, S., Zhao, L., Liu, P., Zhao, L., Ye, F., Wang, H., Zhou, W., Zhu, N., Zhen, W., Yu, H., Zhang, X., Song, Z., Guo, L., Chen, L., Wang, C., Wang, Y., Wang, X., Xiao, Y., Sun, Q., Liu, H., Zhu, F., Ma, C., Yan, L., Yang, M., Han, J., Xu, W., Tan, W., Peng, X., Jin, Q., Wu, G. and Qin, C. 2020b. The Pathogenicity of 2019 Novel Coronavirus in hACE2 Transgenic Mice. bioRxiv, 2020.2002.2007.939389.
Blaurock, C., Breithaupt, A., Weber, S., Wylezich, C., Keller, M., Mohl, B.-P., Görlich, D., Groschup, M.H., Sadeghi, B., Höper, D., Mettenleiter, T.C. and Balkema-Buschmann, A. 2022. Compellingly high SARS-CoV-2 susceptibility of Golden Syrian hamsters suggests multiple zoonotic infections of pet hamsters during the COVID-19 pandemic. Sci. Rep. 12: 15069.
Böswald, L.F., Popper, B., Matzek, D., Neuhaus, K. and Wenderlein, J. 2024. Characterization of the gastrointestinal microbiome of the Syrian hamster (Mesocricetus auratus) and comparison to data from mice. FEBS Open Bio. doi:10.1002/2211-5463.13869
Brola, W. and Wilski, M. 2022. Neurological consequences of COVID-19. Pharmacol Rep 74: 1208-1222.
Campos, R.K., Camargos, V.N., Azar, S.R., Haines, C.A., Eyzaguirre, E.J. and Rossi, S.L. 2021. SARS-CoV-2 Infects Hamster Testes. Microorganisms 9.1318
Carossino, M., Montanaro, P., O'Connell, A., Kenney, D., Gertje, H., Grosz, K., Ericsson, M., Huber, B.R., Subramaniam, S., Kirkland, T.A., Walker, J.R., Francis, K.P., Klose, A.D., Paragas, N., Kurnick, S., Bosmann, M., Saeed, M., Balasuriya, U., Douam, F. and Crossland, N. 2021. Fatal neuroinvasion and SARS-CoV-2 tropism in K18-hACE2 mice is partially independent on hACE2 expression. bioRxiv.2021-01
Chan, J.F.-W., Zhang, A.J., Yuan, S., Poon, V.K.-M., Chan, C.C.-S., Lee, A.C.-Y., Chan, W.-M., Fan, Z., Tsoi, H.-W., Wen, L., Liang, R., Cao, J., Chen, Y., Tang, K., Luo, C., Cai, J.-P., Kok, K.-H., Chu, H., Chan, K.-H., Sridhar, S., Chen, Z., Chen, H., To, K.K.-W. and Yuen, K.-Y. 2020. Simulation of the clinical and pathological manifestations of Coronavirus Disease 2019 (COVID-19) in golden Syrian hamster model: implications for disease pathogenesis and transmissibility. Clinic. Infect. Dis.71(9):2428-2446.
Channappanavar, R., Fett, C., Mack, M., Ten Eyck, P.P., Meyerholz, D.K., Perlman, S., 2017. Sex-Based Differences in Susceptibility to Severe Acute Respiratory Syndrome Coronavirus Infection. J. Immunol. 198: 4046-4053.
Chao Shan, Y.-F.Y., Xing-Lou Yang, Yi-Wu Zhou, Jia Wu, Ge Gao, Yun Peng, Lian Yang, Xue Hu, Jin Xiong, Ren-Di Jiang, Hua-Jun Zhang, Xiao-Xiao Gao, Cheng Peng, Juan Min, Ying Chen, Hao-Rui Si, Peng Zhou, Yan-Yi Wang, Hong-Ping Wei, Wei Pang, Zheng-Fei Hu, Long-Bao Lv, Yong-Tang Zheng, Zheng-Li Shi and Zhi-Ming Yuan. 2020. Infection with novel coronavirus (SARS-CoV-2) causes pneumonia in the rhesus macaques. Cell Res. 30:670-677.
Chen, Y., Wei, Q., Li, R., Gao, H., Zhu, H., Deng, W., Bao, L., Tong, W., Cong, Z., Jiang, H. and Qin, C. 2020. Protection of Rhesus Macaque from SARS-Coronavirus challenge by recombinant adenovirus vaccine. bioRxiv, 2020.2002.2017.951939.
Clark, J.J., Penrice-Randal, R., Sharma, P., Dong, X., Pennington, S.H., Marriott, A.E., Colombo, S., Davidson, A., Kavanagh Williamson, M., Matthews, D.A., Turtle, L., Prince, T., Hughes, G.L., Patterson, E.I., Shawli, G., Mega, D.F., Subramaniam, K., Sharp, J., Turner, J.D., Biagini, G.A., Owen, A., Kipar, A., Hiscox, J.A. and Stewart, J.P. 2024. Sequential Infection with Influenza A Virus Followed by Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Leads to More Severe Disease and Encephalitis in a Mouse Model of COVID-19. Viruses, 16: 863.
Cong, Y., Dixit, S., Perry, D.L., Huzella, L.M., Kollins, E., Byrum, R., Anthony, S.M., Drawbaugh, D., Lembirik, S., Postnikova, E., Eaton, B., Murphy, M., Kocher, G., Hadley, K., Marketon, A.E., Bernbaum, R.M., Hischak, A.M.W., Hart, R., Vaughan, N., Wada, J., Qin, J., St Claire, M.C., Schmaljohn, C.S. and Holbrook, M.R. 2024. Characterization of therapeutic antibody efficacy against multiple SARS-CoV-2 variants in the hamster model. Antiviral Res. 230: 105987.
Cui, L., Wang, J., Orlando, F., Giacconi, R., Malavolta, M., Bartozzi, B., Galeazzi, R., Giorgini, G., Pesce, L., Cardarelli, F., Quagliarini, E., Renzi, S., Xiao, S., Pozzi, D., Provinciali, M., Caracciolo, G., Marchini, C. and Amici, A. 2024. Enhancing Immune Responses against SARS-CoV-2 Variants in Aged Mice with INDUK: A Chimeric DNA Vaccine Encoding the Spike S1-TM Subunits. ACS Omega 9: 34624-34635.
Deng, W., Bao, L., Gao, H., Xiang, Z., Qu, Y., Song, Z., Gong, S., Liu, J., Liu, J., Yu, P., Qi, F., Xu, Y., Li, F., Xiao, C., Lv, Q., Xue, J., Wei, Q., Liu, M., Wang, G., Wang, S., Yu, H., Liu, X., Zhao, W., Han, Y. and Qin, C. 2020. Ocular conjunctival inoculation of SARS-CoV-2 can cause mild COVID-19 in Rhesus macaques. bioRxiv, 2020.2003.2013.990036.
Dhakal, S., Ruiz-Bedoya, C.A., Zhou, R., Creisher, P.S., Villano, J.S., Littlefield, K., Ruelas Castillo, J., Marinho, P., Jedlicka, A.E., Ordonez, A.A., Bahr, M., Majewska, N., Betenbaugh, M.J., Flavahan, K., Mueller, A.R.L., Looney, M.M., Quijada, D., Mota, F., Beck, S.E., Brockhurst, J., Braxton, A.M., Castell, N., Stover, M., D'Alessio, F.R., Metcalf Pate, K.A., Karakousis, P.C., Mankowski, J.L., Pekosz, A., Jain, S.K. and Klein, S.L. 2021. Sex Differences in Lung Imaging and SARS-CoV-2 Antibody Responses in a COVID-19 Golden Syrian Hamster Model. mBio 12: e0097421.
Dhanushkodi, N.R., Prakash, S., Quadiri, A., Zayou, L., Srivastava, R., Shaik, A.M., Suzer, B., Ibraim, I.C., Landucci, G., Tifrea, D.F., Singer, M., Jamal, L., Edwards, R.A., Vahed, H., Brown, L. and BenMohamed, L. 2024. Antiviral and Anti-Inflammatory Therapeutic Effect of RAGE-Ig Protein against Multiple SARS-CoV-2 Variants of Concern Demonstrated in K18-hACE2 Mouse and Syrian Golden Hamster Models. J. Immunol. 212: 576-585.
Drelich, A.K., Rayavara, K., Hsu, J., Saenkham-Huntsinger, P., Judy, B.M., Tat, V., Ksiazek, T.G., Peng, B.H. and Tseng, C.K. 2024. Characterization of Unique Pathological Features of COVID-Associated Coagulopathy: Studies with AC70 hACE2 Transgenic Mice Highly Permissive to SARS-CoV-2 Infection. PLoS Pathog. 20: e1011777.
Edwards, C.T., Karunakaran, K.A., Garcia, E., Beutler, N., Gagne, M., Golden, N., Aoued, H., Pellegrini, K.L., Burnett, M.R., Honeycutt, C.C., Lapp, S.A., Ton, T., Lin, M.C., Metz, A., Bombin, A., Goff, K., Scheuermann, S.E., Wilkes, A., Wood, J.S., Ehnert, S., Weissman, S., Curran, E.H., Roy, M., Dessasau, E., Paiardini, M., Upadhyay, A.A., Moore, I., Maness, N.J., Douek, D.C., Piantadosi, A., Andrabi, R., Rogers, T.R., Burton, D.R. and Bosinger, S.E. 2024. Passive infusion of an S2-Stem broadly neutralizing antibody protects against SARS-CoV-2 infection and lower airway inflammation in rhesus macaques. bioRxiv.2024-07.
Ellsworth, C.R., Wang, C., Katz, A.R., Chen, Z., Islamuddin, M., Yang, H., Scheuermann, S.E., Goff, K.A., Maness, N.J., Blair, R.V., Kolls, J.K. and Qin, X. 2024. Natural Killer Cells Do Not Attenuate a Mouse-Adapted SARS-CoV-2-Induced Disease in Rag2(-/-) Mice. Viruses. 16: 611.
Falzarano, D., de Wit, E., Feldmann, F., Rasmussen, A.L., Okumura, A., Peng, X., Thomas, M.J., van Doremalen, N., Haddock, E., Nagy, L., LaCasse, R., Liu, T., Zhu, J., McLellan, J.S., Scott, D.P., Katze, M.G., Feldmann, H. and Munster, V.J. 2014. Infection with MERS-CoV causes lethal pneumonia in the common marmoset. PLoS Pathog. 10: e1004250.
Feng, X.L., Yu, D., Zhang, M., Li, X., Zou, Q.C., Ma, W., Han, J.B., Xu, L., Yang, C., Qu, W., Deng, Z.H., Long, J., Long, Y., Li, M., Yao, Y.G., Dong, X.Q., Zeng, J. and Li, M.H. 2022. Characteristics of replication and pathogenicity of SARS-CoV-2 Alpha and Delta isolates. Virol Sin. 37: 804-812.
Fumagalli, V., Ravà, M., Marotta, D., Di Lucia, P., Laura, C., Sala, E., Grillo, M., Bono, E., Giustini, L., Perucchini, C., Mainetti, M., Sessa, A., Garcia-Manteiga, J.M., Donnici, L., Manganaro, L., Delbue, S., Broccoli, V., De Francesco, R., D'Adamo, P., Kuka, M., Guidotti, L.G. and Iannacone, M. 2022. Administration of aerosolized SARS-CoV-2 to K18-hACE2 mice uncouples respiratory infection from fatal neuroinvasion. Sci. Immunol. 7: eabl9929.
Ghosh Roy, S., Karim, A.F., Brumeanu, T.D. and Casares, S.A. 2024. Reconstitution of human microglia and resident T cells in the brain of humanized DRAGA mice. Front Cell Infect. Microbiol. 14: 1367566.
Glazkova, D.V., Bogoslovskaya, E.V., Urusov, F.A., Kartashova, N.P., Glubokova, E.A., Gracheva, A.V., Faizuloev, E.B., Trunova, G.V., Khokhlova, V.A., Bezborodova, O.A., Pankratov, A.A., Leneva, I.A. and Shipulin, G.A. 2022. [Generation of SARS-CoV-2 Mouse Model by Transient Expression of the Human ACE2 Gene Mediated by Intranasal Administration of AAV-hACE2]. Mol Biol (Mosk) 56: 774-782.
Goumenou, M., Spandidos, D.A. and Tsatsakis, A. 2020. [Editorial] Possibility of transmission through dogs being a contributing factor to the extreme Covid‑19 outbreak in North Italy. Mol. Med. Rep. 21: 2293-2295.
Greene, C., Connolly, R., Brennan, D., Laffan, A., O'Keeffe, E., Zaporojan, L., O'Callaghan, J., Thomson, B., Connolly, E., Argue, R., Meaney, J.F.M., Martin-Loeches, I., Long, A., Cheallaigh, C.N., Conlon, N., Doherty, C.P. and Campbell, M.2024. Blood-brain barrier disruption and sustained systemic inflammation in individuals with long COVID-associated cognitive impairment. Nat. Neurosci. 27: 421-432.
Guo, H., Yang, Y., Zhao, T., Lu, Y., Gao, Y., Li, T., Xiao, H., Chu, X., Zheng, L., Li, W., Cheng, H., Huang, H., Liu, Y., Lou, Y., Nguyen, H.C., Wu, C., Chen, Y., Yang, H. and Ji, X. 2023. Mechanism of a rabbit monoclonal antibody broadly neutralizing SARS-CoV-2 variants. Commun.Biol. 6: 364.
Haoyu, W., Meiqin, L., Jiaoyang, S., Guangliang, H., Haofeng, L., Pan, C., Xiongzhi, Q., Kaixin, W., Mingli, H., Xuejie, Y., Lämmermann, I., Grillari, J., Zhengli, S., Jiekai, C. and Guangming, W. 2024. Premature aging effects on COVID-19 pathogenesis: new insights from mouse models. Sci. Rep. 14: 19703.
Hoffmann, M., Kleine-Weber, H., Schroeder, S., Krüger, N., Herrler, T., Erichsen, S., Schiergens, T.S., Herrler, G., Wu, N.H., Nitsche, A., Müller, M.A., Drosten, C., Pöhlmann, S., 2020. SARS-CoV-2 Cell Entry Depends on ACE2 and TMPRSS2 and Is Blocked by a Clinically Proven Protease Inhibitor. Cell , 181: 271-280.e278.
Ireland, R.E., Davies, C.D., Keyser, E., Findlay, J.S.F., Eastaugh, L., Laws, T.R., Salguero, F.J., Hunter, L. and Nelson, M. 2022. Histopathological and Immunological Findings in the Common Marmoset Following Exposure to Aerosolized SARS-CoV-2. Viruses 14: 1580.
Jahirul Islam, M., Nawal Islam, N., Siddik Alom, M., Kabir, M. and Halim, M.A. 2023. A review on structural, non-structural, and accessory proteins of SARS-CoV-2: Highlighting drug target sites. Immunobiology 228: 152302.
Jeon, D., Kim, S.H., Kim, J., Jeong, H., Uhm, C., Oh, H., Cho, K., Cho, Y., Park, I.H., Oh, J., Kim, J.J., Hwang, J.Y., Lee, H.J., Lee, H.Y., Seo, J.Y., Shin, J.S., Seong, J.K. and Nam, K.T. 2024. Discovery of a new long COVID mouse model via systemic histopathological comparison of SARS-CoV-2 intranasal and inhalation infection. Biochem. Biophys. Acta Mol. Basis Dis .1870: 167347.
Kim, Y.I., Kim, S.G., Kim, S.M., Kim, E.H., Park, S.J., Yu, K.M., Chang, J.H., Kim, E.J., Lee, S., Casel, M.A.B., Um, J., Song, M.S., Jeong, H.W., Lai, V.D., Kim, Y., Chin, B.S., Park, J.S., Chung, K.H., Foo, S.S., Poo, H., Mo, I.P., Lee, O.J., Webby, R.J., Jung, J.U. and Choi, Y.K. 2020. Infection and Rapid Transmission of SARS-CoV-2 in Ferrets. Cell host Microbe, 27(5):704-709.
Ko, M., Lee, J.Y., Shin, Y.S., Jeon, S., Myung, S., Cho, J.E., Jang, M.S., Song, J.H., Kim, H.R., Park, H.G., Park, C.M. and Kim, S. 2023. Novel SARS-CoV-2 entry inhibitors, 2-anilinoquinazolin-4(3H)-one derivatives, show potency as SARS-CoV-2 antivirals in a human ACE2 transgenic mouse model. J. Med. Virol. 95: e28863.
Lechien, J.R., Chiesa-Estomba, C.M., De Siati, D.R., Horoi, M., Le Bon, S.D., Rodriguez, A., Dequanter, D., Blecic, S., El Afia, F., Distinguin, L., Chekkoury-Idrissi, Y., Hans, S., Delgado, I.L., Calvo-Henriquez, C., Lavigne, P., Falanga, C., Barillari, M.R., Cammaroto, G., Khalife, M., Leich, P., Souchay, C., Rossi, C., Journe, F., Hsieh, J., Edjlali, M., Carlier, R., Ris, L., Lovato, A., De Filippis, C., Coppee, F., Fakhry, N., Ayad, T. and Saussez, S. 2020. Olfactory and gustatory dysfunctions as a clinical presentation of mild-to-moderate forms of the coronavirus disease (COVID-19): a multicenter European study. Eur. Arch. Otorhinolaryngol. 277(8):251-2261.
Lee, K.S., Wong, T.Y., Russ, B.P., Horspool, A.M., Miller, O.A., Rader, N.A., Givi, J.P., Winters, M.T., Wong, Z.Y.A., Cyphert, H.A., Denvir, J., Stoilov, P., Barbier, M., Roan, N.R., Amin, M.S., Martinez, I., Bevere, J.R. and Damron, F.H. 2022. SARS-CoV-2 Delta variant induces enhanced pathology and inflammatory responses in K18-hACE2 mice. PLoS One, 17: e0273430.
Liu, H., Brostoff, T., Ramirez, A., Wong, T., Rowland, D.J., Heffner, M., Flores, A., Willis, B., Evans, J.J., Lanoue, L., Lloyd, K.C.K. and Coffey, L.L. 2024. Establishment and characterization of an hACE2/hTMPRSS2 knock-in mouse model to study SARS-CoV-2. Front. Immunol. 15: 1428711.
Lu, S., Zhao, Y., Yu, W., Yang, Y., Gao, J., Wang, J., Kuang, D., Yang, M., Yang, J., Ma, C., Xu, J., Qian, X., Li, H., Zhao, S., Li, J., Wang, H., Long, H., Zhou, J., Luo, F., Ding, K., Wu, D., Zhang, Y., Dong, Y., Liu, Y., Zheng, Y., Lin, X., Jiao, L., Zheng, H., Dai, Q., Sun, Q., Hu, Y., Ke, C., Liu, H. and Peng, X. 2020. Comparison of SARS-CoV-2 infections among 3 species of non-human primates. bioRxiv, 2020.2004.2008.031807.
Luan, J., Jin, X., Lu, Y. and Zhang, L. 2020. SARS‐CoV‐2 spike protein favors ACE2 from Bovidae and Cricetidae. J.Med.Virol. 92(9):1649-1656.
Mahase, E. 2020. Covid-19: concerns grow over inflammatory syndrome emerging in children. BMJ. 369:m1710.
Melin, A.D., Janiak, M.C., Marrone, F., Arora, P.S. and Higham, J.P. 2020. Comparative ACE2 variation and primate COVID-19 risk. bioRxiv, 2020.2004.2009.034967.
Metzdorf, K., Jacobsen, H., Kim, Y., Teixeira Alves, L.G., Kulkarni, U., Brdovčak, M.C., Materljan, J., Eschke, K., Chaudhry, M.Z., Hoffmann, M., Bertoglio, F., Ruschig, M., Hust, M., Šustić, M., Krmpotić, A., Jonjić, S., Widera, M., Ciesek, S., Pöhlmann, S., Landthaler, M. and Čičin-Šain, L. 2024. A single-dose MCMV-based vaccine elicits long-lasting immune protection in mice against distinct SARS-CoV-2 variants. Front. Immunol. 15: 1383086.
Mohandas, S., Yadav, P.D., Nyayanit, D., Shete, A., Sarkale, P., Hundekar, S., Kumar, S. and Lole, K. 2021. Comparison of SARS-CoV-2 Variants of Concern 202012/01 (U.K. Variant) and D614G Variant Transmission by Different Routes in Syrian Hamsters. Vector Borne Zoonotic Dis. 21: 638-641.
Munster, V.J., Feldmann, F., Williamson, B.N., van Doremalen, N., Pérez-Pérez, L., Schulz, J., Meade-White, K., Okumura, A., Callison, J., Brumbaugh, B., Avanzato, V.A., Rosenke, R., Hanley, P.W., Saturday, G., Scott, D., Fischer, E.R. and de Wit, E. 2020. Respiratory disease and virus shedding in rhesus macaques inoculated with SARS-CoV-2. bioRxiv, 2020.2003.2021.001628.
Myeni, S.K., Leijs, A.A., Bredenbeek, P.J., Morales, S.T., Linger, M.E., Fougeroux, C., van Zanen-Gerhardt, S., Zander, S.A.L., Sander, A.F. and Kikkert, M. 2024. Protection of K18-hACE2 Mice against SARS-CoV-2 Challenge by a Capsid Virus-like Particle-Based Vaccine. Vaccines (Basel) 12(7):766.
Mykytyn, A.Z., Lamers, M.M., Okba, N.M.A., Breugem, T.I., Schipper, D., van den Doel, P.B., van Run, P., van Amerongen, G., de Waal, L., Koopmans, M.P.G., Stittelaar, K.J., van den Brand, J.M.A. and Haagmans, B.L. 2021. Susceptibility of rabbits to SARS-CoV-2. Emerg. Microbes Infect.10 : 1-7.
Nagata, N., Iwata, N., Hasegawa, H., Sato, Y., Morikawa, S., Saijo, M., Itamura, S., Saito, T., Ami, Y., Odagiri, T., Tashiro, M. and Sata, T. 2007. Pathology and virus dispersion in cynomolgus monkeys experimentally infected with severe acute respiratory syndrome coronavirus via different inoculation routes. Int. J. Exp. Pathol. 88: 403-414.
Niu, S., Wang, J., Bai, B., Wu, L., Zheng, A., Chen, Q., Du, P., Han, P., Zhang, Y., Jia, Y., Qiao, C., Qi, J., Tian, W.x., Wang, H.W., Wang, Q. and Gao, G.F. 2021. Molecular basis of cross‐species ACE2 interactions with SARS‐CoV‐2‐like viruses of pangolin origin. The EMBO J. 40: e107786.
Niu, Y., Yu, Y., Bernat, A., Yang, S., He, X., Guo, X., Chen, D., Chen, Y., Ji, S., Si, W., Lv, Y., Tan, T., Wei, Q., Wang, H., Shi, L., Guan, J., Zhu, X., Afanassieff, M., Savatier, P., Zhang, K., Zhou, Q. and Ji, W. 2010. Transgenic rhesus monkeys produced by gene transfer into early-cleavage-stage embryos using a simian immunodeficiency virus-based vector. Proc. Nat. Acad. Sci.USA.107: 17663-17667.
Palmer, C.S., Perdios, C., Abdel-Mohsen, M., Mudd, J., Datta, P.K., Maness, N.J., Lehmicke, G., Golden, N., Hellmers, L., Coyne, C., Moore Green, K., Midkiff, C., Williams, K., Tiburcio, R., Fahlberg, M., Boykin, K., Kenway, C., Russell-Lodrigue, K., Birnbaum, A., Bohm, R., Blair, R., Dufour, J.P., Fischer, T., Saied, A.A. and Rappaport, J. 2024. Non-human primate model of long-COVID identifies immune associates of hyperglycemia. Nat. Commun. 15: 6664.
Park, J.E. and Silva, A.C. 2019. Generation of genetically engineered non-human primate models of brain function and neurological disorders. Am. J.Primatol. 81: e22931.
Plante, J.A., Plante, K.S., Gralinski, L.E., Beall, A., Ferris, M.T., Bottomly, D., Green, R., McWeeney, S.K., Heise, M.T., Baric, R.S. and Menachery, V.D. 2020. Mucin 4 Protects Female Mice from Coronavirus Pathogenesis. bioRxiv, 2020.2002.2019.957118.
Pruijssers, A.J., George, A.S., Schäfer, A., Leist, S.R., Gralinksi, L.E., Dinnon, K.H., Yount, B.L., Agostini, M.L., Stevens, L.J., Chappell, J.D., Lu, X., Hughes, T.M., Gully, K., Martinez, D.R., Brown, A.J., Graham, R.L., Perry, J.K., Du Pont, V., Pitts, J., Ma, B., Babusis, D., Murakami, E., Feng, J.Y., Bilello, J.P., Porter, D.P., Cihlar, T., Baric, R.S., Denison, M.R. and Sheahan, T.P. 2020. Remdesivir potently inhibits SARS-CoV-2 in human lung cells and chimeric SARS-CoV expressing the SARS-CoV-2 RNA polymerase in mice. Cell Reports, 32(3): 107940
Reed, D.S., McElroy, A.K., Barbeau, D.J., McMillen, C.M., Tilston-Lunel, N.L., Nambulli, S., Cottle, E., Gilliland, T.C., Rannulu, H., Lundy, J., Olsen, E.L., O'Malley, K.J., Xia, M., Hartman, A.L., Luke, T.C., Egland, K., Bausch, C., Wu, H., Sullivan, E.J., Klimstra, W.B. and Duprex, W.P. 2024. No evidence for enhanced disease with human polyclonal SARS-CoV-2 antibody in the ferret model. PLoS One, 19: e0290909.
Richard, M., Kok, A., de Meulder, D., Bestebroer, T.M., Lamers, M.M., Okba, N.M.A., van Vlissingen, M.F., Rockx, B., Haagmans, B.L., Koopmans, M.P.G., Fouchier, R.A.M. and Herfst, S. 2020. SARS-CoV-2 is transmitted via contact and via the air between ferrets. bioRxiv, 2020.2004.2016.044503.
Rockx, B., Kuiken, T., Herfst, S., Bestebroer, T., Lamers, M.M., de Meulder, D., van Amerongen, G., van den Brand, J., Okba, N.M.A., Schipper, D., van Run, P., Leijten, L., Verschoor, E., Verstrepen, B., Langermans, J., Drosten, C., van Vlissingen, M.F., Fouchier, R., de Swart, R., Koopmans, M. and Haagmans, B.L. 2020. Comparative Pathogenesis Of COVID-19, MERS And SARS In A Non-Human Primate Model. bioRxiv, 2020.2003.2017.995639.
Seo, S.M., Son, J.H., Lee, J.H., Kim, N.W., Yoo, E.S., Kang, A.R., Jang, J.Y., On, D.I., Noh, H.A., Yun, J.W., Park, J.W., Choi, K.S., Lee, H.Y., Shin, J.S., Seo, J.Y., Nam, K.T., Lee, H., Seong, J.K. and Choi, Y.K. 2022. Development of transgenic models susceptible and resistant to SARS-CoV-2 infection in FVB background mice. PLoS One, 17: e0272019.
Shi, J., Wen, Z., Zhong, G., Yang, H., Wang, C., Huang, B., Liu, R., He, X., Shuai, L., Sun, Z., Zhao, Y., Liu, P., Liang, L., Cui, P., Wang, J., Zhang, X., Guan, Y., Tan, W., Wu, G., Chen, H. and Bu, Z. 2020. Susceptibility of ferrets, cats, dogs, and other domesticated animals to SARS-coronavirus 2. Science. 368 :.1016-1020.
Song, I.W., Washington, M., Leynes, C., Hsu, J., Rayavara, K., Bae, Y., Haelterman, N., Chen, Y., Jiang, M.M., Drelich, A., Tat, V., Lanza, D.G., Lorenzo, I., Heaney, J.D., Tseng, C.K., Lee, B. and Marom, R. 2024. Generation of a humanized mAce2 and a conditional hACE2 mouse models permissive to SARS-COV-2 infection. Mamm Genome 35:113-121.
Souza, A.J.S., Souza Filho, A.F., Zimpel, C.K., Ayupe, M.C., Araújo, M.V., Machado, R.R.G., Salles, E., Salgado, C.L., Tavares, M.S., Silva-Pereira, T.T., Souza, P.C., Durigon, E.L., Heinemann, M.B., Brandão, P.E., Fonseca, D.M.D., Guimarães, A.M.S. and Sá, L.R.M. 2024. Hepatic endotheliitis in Golden Syrian hamsters (Mesocricetus auratus) experimentally infected with SARS-CoV-2. Re.v Inst. Med. Trop. Sao Paulo. 66:e44.
Speranza, E., Purushotham, J.N., Port, J.R., Schwarz, B., Flagg, M., Williamson, B.N., Feldmann, F., Singh, M., Pérez-Pérez, L., Sturdevant, G.L., Roberts, L.M., Carmody, A., Schulz, J.E., van Doremalen, N., Okumura, A., Lovaglio, J., Hanley, P.W., Shaia, C., Germain, R.N., Best, S.M., Munster, V.J., Bosio, C.M. and de Wit, E. 2022. Age-related differences in immune dynamics during SARS-CoV-2 infection in rhesus macaques. Life Sci. Allian.5: e202101314.
Suba, Z. 2020. Prevention and therapy of COVID-19 via exogenous estrogen treatment for both male and female patients. Journal of pharmacy & pharmaceutical sciences : a publication of the Canadian Society for Pharmaceutical Sciences, Societe canadienne des sciences pharmaceutiques, 23:75-85.
Subramaniam, S., Kenney, D., Jayaraman, A., O'Connell, A.K., Walachowski, S., Montanaro, P., Reinhardt, C., Colucci, G., Crossland, N.A., Douam, F. and Bosmann, M. 2024. Aging is associated with an insufficient early inflammatory response of lung endothelial cells in SARS-CoV-2 infection. Front. Immunol. 15: 1397990.
Tatham, L., Kipar, A., Sharp, J., Kijak, E., Herriott, J., Neary, M., Box, H., Gallardo Toledo, E., Valentijn, A., Cox, H., Pertinez, H., Curley, P., Arshad, U., Rajoli, R.K.R., Rannard, S., Stewart, J.P. and Owen, A. 2024. Ronapreve (REGN-CoV; casirivimab and imdevimab) reduces the viral burden and alters the pulmonary response to the SARS-CoV-2 Delta variant (B.1.617.2) in K18-hACE2 mice using an experimental design reflective of a treatment use case. Microbiol Spectr. 12: e0391623.
Trimpert, J., Vladimirova, D., Dietert, K., Abdelgawad, A., Kunec, D., Dökel, S., Voss, A., Gruber, A.D., Bertzbach, L.D. and Osterrieder, N. 2020. The Roborovski Dwarf Hamster Is A Highly Susceptible Model for a Rapid and Fatal Course of SARS-CoV-2 Infection. Cell Reports, 33: 108488-108488.
Wang, Q., Peng, W., Yang, Y., Wu, Y., Han, R., Ding, T., Zhang, X., Liu, J., Yang, J. and Liu, J. 2024. Proteome and ubiquitinome analyses of the brain cortex in K18-hACE2 mice infected with SARS-CoV-2. i.Science, 27: 110602.
Wenham, C., Smith, J. and Morgan, R.2020. COVID-19: the gendered impacts of the outbreak. The Lancet , 395: 846-848.
Williamson, B.N., Feldmann, F., Schwarz, B., Meade-White, K., Porter, D.P., Schulz, J., Doremalen, N.v., Leighton, I., Yinda, C.K., Pérez-Pérez, L., Okumura, A., Lovaglio, J., Hanley, P.W., Saturday, G., Bosio, C.M., Anzick, S., Barbian, K., Cihlar, T., Martens, C., Scott, D.P., Munster, V.J. and Wit, E.d. 2020. Clinical benefit of remdesivir in rhesus macaques infected with SARS-CoV-2. bioRxiv, 2020.2004.2015.043166.
Wong, D.W.L., Klinkhammer, B.M., Djudjaj, S., Villwock, S., Timm, M.C., Buhl, E.M., Wucherpfennig, S., Cacchi, C., Braunschweig, T., Knüchel-Clarke, R., Jonigk, D., Werlein, C., Bülow, R.D., Dahl, E., von Stillfried, S. and Boor, P. 2021. Multisystemic Cellular Tropism of SARS-CoV-2 in Autopsies of COVID-19 Patients. Cells, 10: 1900.
Xia, J., Tong, J., Liu, M., Shen, Y. and Guo, D. 2020. Evaluation of coronavirus in tears and conjunctival secretions of patients with SARS-CoV-2 infection. J. Med. Virol. 92:589-94.
Zhao, X., Chen, D., Szabla, R., Zheng, M., Li, G., Du, P., Zheng, S., Li, X., Song, C., Li, R., Guo, J.-T., Junop, M., Zeng, H. and Lin, H. 2020a. Broad and differential animal ACE2 receptor usage by SARS-CoV-2. bioRxiv, 2020.2004.2019.048710.
Zhao, Y., Wang, J., Kuang, D., Xu, J., Yang, M., Ma, C., Zhao, S., Li, J., Long, H., Ding, K., Gao, J., Liu, J., Wang, H., Li, H., Yang, Y., Yu, W., Yang, J., Zheng, Y., Wu, D., Lu, S., Liu, H. and Peng, X. 2020b. Susceptibility of tree shrew to SARS-CoV-2 infection. Sci. Rep. 10(1): 16007
© 2024 Chithra et al. This is an open access article distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited
Chithra C.S., 2024. Animal Models in COVID-19 Research: Insights and Outcomes. J. Vet. Anim. Sci. 55 (3)